DAX19.984 +0,7%ESt504.899 +0,8%Top 10 Crypto14,75 +0,5%Dow42.992 -0,8%Nas19.722 -1,5%Bitcoin89.854 +0,1%Euro1,0424 ±-0,0%Öl74,23 +0,3%Gold2.628 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Lilium A3CYXP NVIDIA 918422 Novo Nordisk A3EU6F Tesla A1CX3T Bayer BAY001 Allianz 840400 Amazon 906866 Apple 865985 Volkswagen (VW) vz. 766403 BASF BASF11 Rheinmetall 703000 Microsoft 870747 Mercedes-Benz Group (ex Daimler) 710000 Xiaomi A2JNY1 Palantir A2QA4J
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Ruhiger Handel: Dow schließt tiefer -- DAX letztlich in Grün -- Delivery Hero darf Food Panda-Taiwan nicht an Uber verkaufen -- HelloFresh plant Rückkauf eigener Aktien -- Xiaomi, VW im Fokus
Top News
Analyst warnt vor Korrektur des S&P 500: Darum könnte der US-Aktienmarkt 2025 fallen Analyst warnt vor Korrektur des S&P 500: Darum könnte der US-Aktienmarkt 2025 fallen
Krypto-Boom: Diese Bitcoin-Prognosen für 2025 sprengen alle Erwartungen Krypto-Boom: Diese Bitcoin-Prognosen für 2025 sprengen alle Erwartungen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
+++ Einfach investieren ▪ mit Kapitalschutz oder Teilschutz ▪ raiffeisenzertifikate.at ▪ jetzt in Zeichnung +++

Abbott Laboratories Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
110,02 EUR +0,40 EUR +0,36 %
FSE
115,00 USD -0,26 USD -0,23 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.191,24 Mrd. EUR

KGV33,77Div. Rendite1,89%

WKN850103

ISINUS0028241000

SymbolABT

Abbott Laboratories Aktien News

DatumMeistgelesen
PR NewswireAbbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta
PR NewswireAbbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
PR NewswireAbbott Increases Quarterly Dividend for 53rd Consecutive Year
Wer­bungAbbott Laboratories-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireUniversity of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
PR NewswireAbbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
PR NewswireAbbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
PR NewswireAbbott eröffnet eine hochmoderne globale Produktionsstätte in Kilkenny, Irland
PR NewswireNew Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management
PR NewswireAbbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
PR NewswireAbbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
PR NewswireAbbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'
PR NewswireAbbott Hosts Conference Call for Third-Quarter Earnings
PR NewswireAbbott Declares 403rd Consecutive Quarterly Dividend
PR NewswireAbbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
PR NewswireAbbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression
PR NewswireAbbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores
PR NewswireAbbott's AVEIR™ DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in Canada
PR NewswireQuebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with Diabetes
PR NewswireAbbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
PR NewswireAbbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
PR NewswireCadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
PR NewswireAbbott Hosts Conference Call for Second-Quarter Earnings
PR NewswireAbbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
PR NewswireAbbott Declares 402nd Consecutive Quarterly Dividend
PR NewswireAbbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
PR NewswireCadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
PR NewswireAbbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
PR NewswireAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
PR NewswireAbbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
PR NewswireAbbott Hosts Conference Call for First-Quarter Earnings
PR NewswireCanadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System
PR NewswireReal-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
PR NewswireAbbott Declares 401st Consecutive Quarterly Dividend
PR NewswireFDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve
PR NewswireNew Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again
PR NewswireAbbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey
PR NewswireAbbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+
PR NewswireAbbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Hosts Conference Call for Fourth-Quarter Earnings

Abbott Laboratories News

Abbott Laboratories News: auf dieser Seite finden Sie alle Abbott Laboratories News und Nachrichten zur Abbott Laboratories Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Abbott Laboratories News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Abbott Laboratories News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.